Astragalus Polysaccharides 250 mg

DRUG2 trials

Sponsors

PhytoHealth Corporation, Taipei Medical University

Conditions

Cancer-related Fatigue

Phase 4

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

CompletedNCT01720550

PhytoHealth CorporationCancer-related Fatigue

Start: 2012-11-30End: 2017-06-30Updated: 2025-06-04

Unknown Phase

Effects of PG2 on Fatigue-Related Symptom Clusters

CompletedNCT02740959

Taipei Medical UniversityCancer-related Fatigue

Start: 2016-03-31End: 2017-05-08Updated: 2018-09-12

Related Papers

PG2 injection, a novel botanical drug approved for improving cancer-related fatigue among advanced cancer patients under standard palliative care: A double blind, multi-center, randomized phase IV study.

Journal of Clinical Oncology2018-05-20